Cipla Limited · 66-66 · INDIA
For Cipla Limited · 66-66 · INDIA, import alert is 66-66; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; country is INDIA; product is Mebendazole; product code is 60 W - - 16 Mebendazole (Anthelmintic); date published is 10/09/2013; address is Patalganga Industrial Area , Plot No A-2, A-33, A-37/2/2, A-42 , Raigad, Maharashtra INDIA, verified against its source on 2026-09-16.
- Firm
- Cipla Limited verified
- Import alert
- 66-66
- Import alert name
- "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
- Country
- INDIA verified
- Address
- Patalganga Industrial Area , Plot No A-2, A-33, A-37/2/2, A-42 , Raigad, Maharashtra INDIA verified
- Date published
- 10/09/2013 verified
- Product code
- 60 W - - 16 Mebendazole (Anthelmintic) verified
- Product
- Mebendazole verified
What the source says
Cipla Limited Date Published : 10/09/2013 Patalganga Industrial Area , Plot No A-2, A-33, A-37/2/2, A-42 , Raigad, Maharashtra INDIA 60 W - - 16 Mebendazole (Anthelmintic) Date Published: 10/09/2013 Desc: Mebendazole
— accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_202.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.